Department of Obstetrics and Gynaecology, University of British Columbia, Vancouver, BC V6T 2A1, Canada.
Women's Health Research Institute, Vancouver, BC V6H 2N9, Canada.
Biomolecules. 2024 May 15;14(5):583. doi: 10.3390/biom14050583.
Endometriosis is a gynecological disorder associated with local inflammation and neuroproliferation. Increased nerve bundle density has been attributed to increased expression of nerve growth factor (NGF) and interleukin-1β (IL-1β). Immunohistochemical analysis was carried out on 12 patients presenting with all three anatomic subtypes of endometriosis (deep, superficial peritoneal, endometrioma) at surgery, with at least two surgically excised subtypes available for analysis. Immunolocalization for nerve bundle density around endometriosis using protein gene product 9.5 (PGP9.5), as well as NGF and IL-1β histoscores in endometriosis epithelium/stroma, was performed to evaluate differences in scores between lesions and anatomic subtypes per patient. Intra-individual heterogeneity in scores across lesions was assessed using the coefficient of variation (CV). The degree of score variability between subtypes was evaluated using the percentage difference between mean scores from one subtype to another subtype for each marker. PGP9.5 nerve bundle density was heterogenous across multiple subtypes of endometriosis, ranging from 50.0% to 173.2%, where most patients (8/12) showed CV ≥ 100%. The percentage difference in scores showed that PGP9.5 nerve bundle density and NGF and IL-1β expression were heterogenous between anatomic subtypes within the same patient. Based on these observations of intra-individual heterogeneity, we conclude that markers of neuroproliferation in endometriosis should be stratified by anatomic subtype in future studies of clinical correlation.
子宫内膜异位症是一种与局部炎症和神经增生有关的妇科疾病。神经束密度的增加归因于神经生长因子(NGF)和白细胞介素-1β(IL-1β)表达增加。对 12 名在手术中表现出所有三种解剖亚型(深部、浅表腹膜、子宫内膜瘤)的子宫内膜异位症患者进行了免疫组织化学分析,至少有两种手术切除的亚型可供分析。使用蛋白基因产物 9.5(PGP9.5)对子宫内膜异位症周围神经束密度进行免疫定位,以及对子宫内膜异位症上皮/基质中的 NGF 和 IL-1β组织评分进行分析,以评估每个患者病变和解剖亚型之间评分的差异。使用变异系数(CV)评估病变之间评分的个体内异质性。使用每个标志物从一种亚型到另一种亚型的平均评分之间的差异百分比评估亚型之间评分的变化程度。PGP9.5 神经束密度在多种子宫内膜异位症亚型中存在异质性,范围从 50.0%到 173.2%,其中大多数患者(8/12)CV≥100%。评分的差异百分比表明,PGP9.5 神经束密度和 NGF 和 IL-1β 的表达在同一患者的解剖亚型之间存在异质性。基于这些个体内异质性的观察结果,我们得出结论,在未来与临床相关性相关的研究中,子宫内膜异位症中的神经增生标志物应按解剖亚型进行分层。